Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

May 3, 2021 Leave a comment
 A number of energetic vaccination approaches have confirmed ineffective in lowering the substantial morbidity and mortality attributable to respiratory syncytial virus (RSV) in infants and older adults (aged ≥65 years). A vaccine conferring a considerable and sustainable enhance in neutralising exercise is required to guard towards extreme RSV illness. To that finish, we evaluated the security and immunogenicity of DS-Cav1, a prefusion F subunit vaccine. On this part 1 research, DS-Cav1 vaccination was secure and effectively tolerated. DS-Cav1 vaccination elicited a strong enhance in RSV F-specific antibodies and neutralising exercise that was sustained above baseline for no less than 44 weeks.

On this randomised, open-label, part 1 scientific trial, the stabilised prefusion F vaccine DS-Cav1 was evaluated for dose, security, tolerability, and immunogenicity in wholesome adults aged 18-50 years at a single US web site. Individuals had been assigned to obtain escalating doses of both 50 μg, 150 μg, or 500 μg DS-Cav1 at weeks Zero and 12, and had been randomly allotted in a 1:1 ratio inside every dose group to obtain the vaccine with or with out aluminium hydroxide (AlOH) adjuvant. A single low-dose of pre-F immunisation of antigen-experienced people may confer safety that extends all through a complete RSV season.

After 71 individuals had been randomised, the protocol was amended to permit some individuals to obtain a single vaccination at week 0. The first goals evaluated the security and tolerability at each dose inside 28 days following every injection. Neutralising exercise and RSV F-binding antibodies had been evaluated from week Zero to week 44 as secondary and exploratory goals. Security was assessed in all individuals who acquired no less than one vaccine dose; secondary and exploratory immunogenicity evaluation included all individuals with out there knowledge at a given go to.

European knowledge sources for computing burden of (potential) vaccine-preventable illnesses in ageing adults

To information decision-making on immunisation programmes for ageing adults in Europe, one of many goals of the Vaccines and InfecTious illnesses within the Ageing popuLation (IMI2-VITAL) venture is to evaluate the burden of illness (BoD) of (doubtlessly) vaccine-preventable illnesses ((P)VPD). We aimed to establish the out there knowledge sources to calculate the BoD of (P)VPD in taking part VITAL international locations and to pinpoint knowledge gaps. Primarily based on epidemiological standards and vaccine availability, we prioritized (P) VPD attributable to Further-intestinal pathogenic Escherichia coli (ExPEC), norovirus, respiratory syncytial virus, Staphylococcus aureus, and pneumococcal pneumonia.

Morbidity and mortality knowledge had been typically out there for all 5 illnesses, whereas abstract BoD estimates had been largely missing. Out there knowledge weren’t all the time stratified by age and danger group, which is very necessary when calculating BoD for ageing adults. AMR knowledge had been out there in a number of international locations for S. aureus and ExPEC. This research offers an exhaustive overview of the out there knowledge sources and knowledge gaps for the estimation of BoD of 5 (P) VPD in ageing adults within the EU/EAA, which is helpful to information pathogen-specific BoD research and contribute to calculation of (P)VPDs BoD.

Respiratory syncytial virus (RSV) is a typical pathogen inflicting extreme respiratory sickness in infants and elder adults. The event of an efficient RSV vaccine is a crucial unmet medical want and an space of energetic analysis. The normal methodology for testing neutralizing antibodies towards RSV in scientific trials is the plaque discount neutralization take a look at (PRNT), which makes use of 24-well plates and wishes six days publish an infection to develop viral plaques.

On this research, we’ve got developed a virus discount neutralization take a look at (VRNT), which permits the variety of RSV contaminated cells to be routinely counted by an imaging cytometer at someday publish an infection in 96-well plates. VRNT was discovered sturdy to cell seeding density, detection antibody focus, virus enter and an infection time.

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Balancing Precision vs. Cohort Transcriptomic Evaluation of Acute and Restoration Part of Viral Bronchiolitis

Viral infections affecting the decrease respiratory tract place monumental burdens on hospitals. As neither vaccines nor anti-viral brokers exist for a lot of viruses, understanding danger elements and outcomes in every affected person utilizing minimally invasive evaluation, similar to blood, can result in improved healthcare supply. A cohort of PAXGene RNAseq of infants admitted with reasonable or extreme acute bronchiolitis and respiratory syncytial virus (RSV) had been in contrast with case-control statistical evaluation and cohort-based outlier mapping for precision transcriptomics.

Extreme bronchiolitis sufferers had signatures linked to the immune system, interferon signaling, and cytokine signaling, with marked intercourse variations in XIST, RPS4Y1, KDM5D, and LINC00278 for severity. A number of sufferers had distinctive secondary infections, cytokine activation, immune responses, organic pathways, and immune cell activation, highlighting the necessity for outlining patient-level transcriptomic signatures. Balancing relative contributions of cohort-based biomarker discoveries with affected person’s organic responses is required to grasp totality of mechanisms of hostile outcomes in viral bronchiolitis.

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug
QP10912-10ug 10ug
EUR 241.2

VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus)
PROTQ2F842 Regular: 10ug
EUR 380.4
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa.

VEGFE protein (Orf virus)
30R-AV011 5 ug
EUR 537.6
Description: Purified recombinant VEGFE protein (Orf virus)

Recombinant Orf Virus VEGFE Protein
VAng-Lsx0417-inquire inquire Ask for price
Description: Orf Virus VEGFE, recombinant protein from Baculovirus.

Recombinant Orf Virus VEGFE Protein [His]
VAng-Lsx0418-inquire inquire Ask for price
Description: Orf Virus VEGFE [His], recombinant protein from E. coli.

Hepatitis E virus ORF 2 recombinant antigen
8942 100 ug
EUR 477.6
Description: This is Hepatitis E virus ORF 2 recombinant antigen for ELISA,WB.

Hepatitis E virus ORF 2 recombinant antigen
8943 100 ug
EUR 477.6
Description: This is Hepatitis E virus ORF 2 recombinant antigen for ELISA,WB.

Hepatitis E virus ORF 3 recombinant antigen
8944 100 ug
EUR 477.6
Description: This is Hepatitis E virus ORF 3 recombinant antigen for ELISA,WB.

Hepatitis E virus ORF 3 Recombinant Protein
53-335 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 3 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein
53-336 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein
53-337 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
20-abx263083
  • EUR 393.60
  • EUR 10382.40
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Hepatitis E Virus antibody
70R-HR003 100 ug
EUR 418.8
Description: Affinity purified Rabbit polyclonal Hepatitis E Virus antibody

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
7-01759 2µg Ask for price

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
7-01760 10µg Ask for price

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
7-01761 1mg Ask for price

Anti-Zika Virus Envelope Protein E Antibody
STJ503579 100 µg
EUR 571.2

Hepatitis E Virus ORF3 Protein
20-abx260138
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant Hepatitis E Virus ORF3 
7-07450 100µg Ask for price

Recombinant Hepatitis E Virus ORF3 
7-07451 500µg Ask for price

Recombinant Hepatitis E Virus ORF3 
7-07452 1000µg Ask for price

Anti-Zika Virus Envelope Protein E Antibody FITC
STJ503581 100 µg
EUR 703.2

Anti-Zika Virus Envelope Protein E Antibody BIOTIN
STJ503580 100 µg
EUR 703.2

Hepatitis E Virus protein
30R-AH054X 500 ug
EUR 1383.6
Description: Hepatitis E Virus Mosaic recombinant protein

Hepatitis E Virus protein
30-AH29 1 mg
EUR 1196.4
Description: Hepatitis E Virus recombinant protein

Cytochalasin E
C197-1MG 1 mg
EUR 157.2

Cytochalasin E
C197-5MG 5 mg
EUR 462

Deoxybrevianamide E
D083-1MG 1 mg
EUR 333.6

Deoxybrevianamide E
D083-5MG 5 mg
EUR 1076.4

Oligomycin E
O021-1MG 1 mg
EUR 381.6

Oligomycin E
O021-5MG 5 mg
EUR 1248

Paraherquamide E
P070-0.5MG 0.5 mg
EUR 480

Paraherquamide E
P070-2.5MG 2.5 mg
EUR 1590

Phenelfamycin E
P078-1MG 1 mg
EUR 381.6

Phenelfamycin E
P078-5MG 5 mg
EUR 1248

Roquefortine E
R035-1MG 1 mg
EUR 268.8

Roquefortine E
R035-5MG 5 mg
EUR 849.6

Anti-Zika Virus Envelope (E) Protein monoclonal Antibody
CABT-B8528 1 mg
EUR 1064.4

Hepatitis E Virus ORF2 (452-617) Protein
20-abx260268
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Hepatitis E Virus ORF2 (633-659) Protein
20-abx260269
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Hepatitis E Virus ORF2 (403-461) Protein
20-abx260270
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Mouse anti- hepatitis E virus IgM antibody ELISA Kit
ELA-E1791m 96 Tests
EUR 1038

Recombinant Hepatitis E Virus ORF2  (633-659)
7-07441 100µg Ask for price

Recombinant Hepatitis E Virus ORF2  (633-659)
7-07442 500µg Ask for price

Recombinant Hepatitis E Virus ORF2  (633-659)
7-07443 1000µg Ask for price

Recombinant Hepatitis E Virus ORF2  (403-461)
7-07444 100µg Ask for price

Recombinant Hepatitis E Virus ORF2  (403-461)
7-07445 500µg Ask for price

Recombinant Hepatitis E Virus ORF2  (403-461)
7-07446 1000µg Ask for price

Recombinant Hepatitis E Virus ORF2  (452-617)
7-07447 100µg Ask for price

Recombinant Hepatitis E Virus ORF2  (452-617)
7-07448 500µg Ask for price

Recombinant Hepatitis E Virus ORF2  (452-617)
7-07449 1000µg Ask for price

Hepatitis B Virus E Antigen Antibody
20-abx134030
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody
20-abx134031
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

QPCR Kit DNA Orf virus
MOL8844 EACH
EUR 1004.01

Hepatitis E virus PCR kit
PCR-H498-48R 50T
EUR 987.6

Hepatitis E virus PCR kit
PCR-H498-96R 100T
EUR 1335.6

Dengue virus 1 E recombinant antigen
8812 100 ug
EUR 477.6
Description: This is Dengue virus 1 E recombinant antigen for ELISA,WB.

Dengue virus 2 E recombinant antigen
8813 100 ug
EUR 477.6
Description: This is Dengue virus 2 E recombinant antigen for ELISA,WB.

Dengue virus 3 E recombinant antigen
8814 100 ug
EUR 477.6
Description: This is Dengue virus 3 E recombinant antigen for ELISA,WB.

Dengue virus 4 E recombinant antigen
8815 100 ug
EUR 477.6
Description: This is Dengue virus 4 E recombinant antigen for ELISA,WB.

Swine HEPATITIS E virus Antibodies IgM
QY-E40197 96T
EUR 480

Swine HEPATITIS E virus Antibodies IgG
QY-E40198 96T
EUR 480

Recombinant (E.Coli) Hepatitis E Virus (HEV) ORF3 
RP-531 100 ug
EUR 343.2

Hepatitis E Virus protein (HRP)
65-IH35 1 ml
EUR 1326
Description: Purified recombinant Hepatitis E Virus protein (HRP)

Hepatitis E Virus Genotype 1 Protein ORF3 (ORF3) Antibody
20-abx109423
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Rabbit Anti-Mumps virus (Enders) Virus antiserum
MUMS11-S 0.1 ml
EUR 548.4

Rabbit Anti-Mumps virus (Enders) Virus antiserum
MUMS11-SB 0.5 ml
EUR 1074

Recombinant Zika Virus E Protein
VAng-Lsx0581-100g 100 µg
EUR 1365.6
Description: Zika Virus Envelope, recombinant protein from Insect cells.

Monoclonal Anti-Mumps virus (Enders) Virus IgG
MUMS12-M 100 ul
EUR 489.6

Hepatitis E virus genotype 1 Protein ORF3 Antibody (HRP)
20-abx109152
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Human anti-hepatitis B virus e antibody,HBeAb ELISA Kit
201-12-1603 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Mouse Anti-Hepatitis B Virus E Antibody (HBeAb) ELISA Kit
abx053819-96tests 96 tests
EUR 801.6

Human anti-hepatitis B virus e antibody, HBeAb ELISA Kit
CSB-E09570h-24T 1 plate of 24 wells
EUR 198
Description: Qualitative competitive ELISA kit for measuring Human anti-hepatitis B virus e antibody, HBeAb in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human anti-hepatitis B virus e antibody, HBeAb ELISA Kit
1-CSB-E09570h
  • EUR 667.20
  • EUR 4634.40
  • EUR 2472.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Qualitative competitive ELISA kit for measuring Human anti-hepatitis B virus e antibody, HBeAb in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human anti-hepatitis B virus e antibody(HBeAb)ELISA Kit
GA-E1619HM-48T 48T
EUR 346.8

Human anti-hepatitis B virus e antibody(HBeAb)ELISA Kit
GA-E1619HM-96T 96T
EUR 559.2

Human anti-hepatitis B virus e antibody(HBeAb)ELISA Kit
QY-E02515 96T
EUR 433.2

Hepatitis B Virus E Antigen Antibody (HRP)
20-abx134032
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody (HRP)
20-abx134033
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis E virus genotype 1 Protein ORF3 Antibody (FITC)
20-abx107734
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Hepatitis B Virus E Antigen Antibody (FITC)
20-abx134034
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody (FITC)
20-abx134035
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis E virus genotype 1 Protein ORF3 (ORF3)
1-CSB-EP527126HVZ
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Hepatitis E virus genotype 1 Protein ORF3 (ORF3) expressed in E.coli

QPCR Kit DNA Orf virus Mmix
MOL8846 EACH
EUR 1274.27

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021771-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021772-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021773-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021774-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021775-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021798-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021799-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021800-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021801-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021802-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021803-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021804-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody
abx021805-1mg 1 mg
EUR 886.8

Hepatitis E virus genotype 1 Protein ORF3 Antibody (Biotin)
20-abx106321
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Hepatitis B Virus E Antigen Antibody (Biotin)
20-abx134036
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody (Biotin)
20-abx134037
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis E virus RT PCR kit
RTq-H498-100R 100T
EUR 1573.2

Hepatitis E virus RT PCR kit
RTq-H498-150R 150T
EUR 2144.4

Hepatitis E virus RT PCR kit
RTq-H498-50R 50T
EUR 1155.6

Recombinant Hepatitis E Virus (HEV) ORF2 Antigen (a.a. 633-659)
DAG578 100ug
EUR 786

Recombinant Hepatitis E Virus (HEV) ORF3 antigen (a.a. 92-123)
DAG579 100ug
EUR 786

Recombinant Hepatitis E Virus (HEV) ORF2 Antigen (a.a. 403-461)
DAG580 100ug
EUR 786

Hepatitis B virus e ag recombinant antigen
8915 100 ug
EUR 673.36
Description: This is Hepatitis B virus e ag recombinant antigen for ELISA,WB.

QPCR Kit RNA Hepatitis E virus
MOL6646 EACH
EUR 1045.79

Azithromycin impurity E EvoPure®
A074-5MG 5 mg
EUR 835.2

Hepatitis E virus genotype 1 Capsid protein (ORF2)
1-CSB-BP727851HVZ
  • EUR 913.20
  • EUR 367.20
  • EUR 2341.20
  • EUR 1231.20
  • EUR 1706.40
  • EUR 517.20
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Hepatitis E virus genotype 1 Capsid protein(ORF2) expressed in Baculovirus

Hepatitis E virus genotype 1 Capsid protein (ORF2)
1-CSB-EP727851HVZ
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Hepatitis E virus genotype 1 Capsid protein(ORF2) expressed in E.coli

Hepatitis E virus genotype 3 Capsid protein (ORF2)
1-CSB-YP897430HHAM
  • EUR 814.80
  • EUR 402.00
  • EUR 2606.40
  • EUR 1261.20
  • EUR 1730.40
  • EUR 522.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Hepatitis E virus genotype 3 Capsid protein(ORF2),partial expressed in Yeast

Hepatitis E virus genotype 3 Capsid protein (ORF2)
1-CSB-EP897430HHAMa2
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Hepatitis E virus genotype 3 Capsid protein(ORF2),partial expressed in E.coli

Dengue virus 1 E antigen Recombinant Protein
53-307 0.01 mg
EUR 651.3
Description: Dengue virus 1 E antigen Recombinant Protein

Dengue virus 2 E antigen Recombinant Protein
53-308 0.01 mg
EUR 651.3
Description: Dengue virus 2 E antigen Recombinant Protein

Dengue virus 3 E antigen Recombinant Protein
53-309 0.01 mg
EUR 651.3
Description: Dengue virus 3 E antigen Recombinant Protein

Dengue virus 4 E antigen Recombinant Protein
53-310 0.01 mg
EUR 651.3
Description: Dengue virus 4 E antigen Recombinant Protein

Hepatitis E virus (ratHEV) PCR kit
PCR-V372-48R 50T
EUR 987.6

Hepatitis E virus (ratHEV) PCR kit
PCR-V372-96R 100T
EUR 1335.6

Recombinant Hepatitis E Virus, ORF2 And ORF3 Antigen, GST-tagged
DAG512 1mg
EUR 1537.2

Hepatitis E Virus Mosaic ORF2 / ORF3 38.5 kDa Protein
20-abx260137
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant (E.Coli) Hepatitis E Virus (HEV) ORF2  (633-659)
RP-529 100 ug
EUR 343.2

Recombinant (E.Coli) Hepatitis E Virus (HEV) ORF2  (403-461)
RP-530 100 ug
EUR 343.2

ELISA kit for Human anti-hepatitis B virus e antibody,HBeAb
EK0153 96 tests
EUR 794.4
Description: Enzyme-linked immunosorbent assay kit for quantification of Human anti-hepatitis B virus e antibody,HBeAb in samples from serum, plasma, tissue homogenates and other biological fluids.

Hepatitis B virus E antigen Recombinant Protein
53-314 0.01 mg
EUR 852.9
Description: Hepatitis B virus E antigen Recombinant Protein

Hepatitis B Virus e-Antigen Protein
20-abx260781
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 25 ug
  • 5 ug

Recombinant Hepatitis E Virus Mosaic ORF2/ORF3 38.5 kDa
7-07438 100µg Ask for price

Recombinant Hepatitis E Virus Mosaic ORF2/ORF3 38.5 kDa
7-07439 500µg Ask for price

Recombinant Hepatitis E Virus Mosaic ORF2/ORF3 38.5 kDa
7-07440 1000µg Ask for price

Mouse antibody for Hepatitis B virus e antigen
1892 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against Hepatitis B virus e antigen for WB, ELISA.

Mouse antibody for Hepatitis B virus e antigen
1893 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against Hepatitis B virus e antigen for WB, ELISA.

Mouse antibody for Hepatitis B virus e antigen
1894 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against Hepatitis B virus e antigen for WB, ELISA.

anti- VEGF antibody
FNab09391 100µg
EUR 658.5
Description: Antibody raised against VEGF

Anti- VEGF antibody
FNab09933 100µg
EUR 658.5
Description: Antibody raised against VEGF

Anti-Rabies Virus antibody
STJ16100770 100 µg
EUR 424.8

Recombinant Hepatitis E Virus Mosaic-S ORF2/ORF3 33kDa
7-07435 100µg Ask for price

Recombinant Hepatitis E Virus Mosaic-S ORF2/ORF3 33kDa
7-07436 500µg Ask for price

Recombinant Hepatitis E Virus Mosaic-S ORF2/ORF3 33kDa
7-07437 1000µg Ask for price

Recombinant Hepatitis B Virus e-Antigen
7-07423 5µg Ask for price

Recombinant Hepatitis B Virus e-Antigen
7-07424 25µg Ask for price

Recombinant Hepatitis B Virus e-Antigen
7-07425 1000µg Ask for price

Human Hepatitis E virus antibody(IgG)ELISA Kit
CSB-E04811h-24T 1 plate of 24 wells
EUR 198
Description: Qualitative indirect ELISA kit for measuring Human Hepatitis E virus antibody (IgG) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Respiratory Syncytial Virus (RSV) is the foremost explanation for decrease respiratory tract an infection in infants, in whom, the sensing of RSV by innate immune receptors and its regulation are nonetheless poorly described. Nevertheless, the extreme bronchiolitis following RSV an infection in neonates has been related to a defect in sort I interferons (IFN-I) manufacturing, a cytokine produced primarily by alveolar macrophages (AMs) upon RSV an infection in adults. Within the current research, neonatal C57BL/6 AMs mobilized very weakly the IFN-I pathway upon RSV an infection in vitro and did not restrain virus replication.

Leave a Reply

Your email address will not be published. Required fields are marked *